Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: ALTEOGEN Inc.

Capitalization 20,083B 13.7B 11.77B 10.64B 10.18B 18.6B 1,258B 19.19B 125B 50.16B 603B 51.42B 50.33B 2,160B P/E ratio 2025 *
286x
P/E ratio 2026 * 60.2x
Enterprise value 20.03B 13.66M 11.73M 10.61M 10.15M 18.55M 1.26B 19.13M 125M 50.02M 602M 51.28M 50.19M 2.15B EV / Sales 2025
111x
EV / Sales 2026 * 34.4x
Free-Float
72.75%
Yield 2025 *
-
Yield 2026 * -
1 day+2.46%
1 week-1.96%
Current month-7.85%
1 month-0.66%
3 months-17.74%
6 months-22.74%
Current year-16.46%
1 week 350,000
Extreme 350000
389,000
1 month 327,000
Extreme 327000
419,000
Current year 327,000
Extreme 327000
529,000
1 year 315,500
Extreme 315500
569,000
3 years 31,950
Extreme 31950
569,000
5 years 27,875
Extreme 27875
569,000
10 years 3,645.83
Extreme 3645.8333
569,000
Manager TitleAgeSince
Comptroller/Controller/Auditor 60 28/03/2021
Corporate Officer/Principal 60 -
Director TitleAgeSince
Chairman 71 12/05/2008
Director/Board Member 69 28/03/2021
Change 5d. change 1-year change 3-years change Capi.($)
+2.46%-1.96%+0.94%+957.75% 13.27B
-1.22%+0.70%+3.65%+3.35% 80.21B
+2.69%+4.11%+55.43%+228.22% 56.58B
+0.82%+59.20%+59.20%+59.20% 49.5B
-1.67%-0.48%-43.57%-49.80% 48.23B
+0.09%+2.39%+25.01%-26.56% 27.63B
-1.36%+10.34%+52.89%-60.24% 22.01B
-1.11%-2.09%+34.99%+33.34% 19.32B
-0.41%+10.12%+114.70%+117.98% 18.14B
+3.41%+1.62%+30.84%+62.25% 14.12B
Average +0.37%+4.19%+33.41%+132.55% 34.9B
Weighted average by Cap. +0.11%+3.14%+26.70%+80.30%

Financials

2025 2026 *
Net sales 208B 142M 122M 110M 106M 193M 13.05B 199M 1.3B 520M 6.26B 533M 522M 22.4B 580B 396M 340M 307M 294M 537M 36.35B 554M 3.62B 1.45B 17.43B 1.49B 1.45B 62.4B
Net income 66.46B 45.34M 38.94M 35.2M 33.7M 61.55M 4.16B 63.49M 415M 166M 2B 170M 167M 7.15B 341B 233M 200M 181M 173M 316M 21.39B 326M 2.13B 853M 10.26B 874M 856M 36.72B
Net Debt -55.67B -37.98M -32.61M -29.48M -28.23M -51.55M -3.49B -53.18M -347M -139M -1.67B -143M -140M -5.99B -121B -82.33M -70.7M -63.91M -61.19M -112M -7.56B -115M -753M -301M -3.63B -309M -302M -12.98B
Logo ALTEOGEN Inc.
Alteogen Inc. is a Korea-based company mainly engaged in the research and development of biopharmaceuticals. The Company operates biobetter business segment, which develops protein pharmaceuticals and cancer therapies, and bio similar business segment, which develops bio similar and animal medicines. The Company mainly provides growth hormone, herceptin, humira, antibodies, animal drugs and others.
Employees
159
Date Price Change Volume
10/03/26 375,500.00 +2.46% 314,319
09/03/26 366,500.00 -1.74% 310,934
06/03/26 373,000.00 +0.27% 312,462
05/03/26 372,000.00 +12.05% 641,312
04/03/26 332,000.00 -13.32% 759,912
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
375,500.00KRW
Average target price
435,000.00KRW
Spread / Average Target
+15.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A196170 Stock
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW